Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Merck & Co. 16.286, Moderna 0.145.
Merck & Co. vs Moderna Net Worth and Market Cap
Merck & Co. (MRK) and Moderna (MRNA) are peers in Vaccines. Merck & Co. reported revenue of $16.3B as of Q1 2026, compared with $145M for Moderna. Merck & Co. leads on revenue.
Merck & Co.'s gross margin is 81.9% versus 35.9% for Moderna. Merck & Co.'s net margin is -26.0% versus -539.3% for Moderna.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Merck & Co., Moderna.| Metric | Merck & Co. | Moderna |
|---|---|---|
| Market Cap | - | - |
| Revenue | $16.29B | $145.00M |
| Cost of Revenue | $2.94B | $93.00M |
| Gross Profit | $13.34B | $52.00M |
| Operating Income | $-1.88B | $-815.00M |
| Net Income | $-4.24B | $-782.00M |
| R&D Expense | $12.56B | $651.00M |
| Earnings Per Share | -$1.72 | -$1.96 |
| Gross Margin | 81.9% | 35.9% |
| Operating Margin | -11.6% | -562.1% |
| Net Profit Margin | -26.0% | -539.3% |
| Free Cash Flow | $2.93B | $-563.00M |
| Cumulative Free Cash Flow | $245.22B | $7.37B |
| Operating Cash Flow | $3.92B | $-526.00M |
| Cash & Equivalents | $5.33B | $1.72B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.